Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Endocrine 5NET 3Thoracic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 536Neoplasms 432Carcinoma, Non-Small-Cell Lung 403Prostatic Neoplasms 334Colorectal Neoplasms 302Lung Neoplasms 262Multiple Myeloma 229Neoplasm Metastasis 186Leukemia, Myeloid, Acute 183Pancreatic Neoplasms 182Ovarian Neoplasms 166Melanoma 143Squamous Cell Carcinoma of Head and Neck 137Recurrence 114Carcinoma, Hepatocellular 113Carcinoma, Renal Cell 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 111Stomach Neoplasms 109Lymphoma 109Head and Neck Neoplasms 108Endometrial Neoplasms 105Brain Neoplasms 104Lymphoma, Non-Hodgkin 102Glioblastoma 99Urinary Bladder Neoplasms 93Triple Negative Breast Neoplasms 92Uterine Cervical Neoplasms 89Hematologic Neoplasms 88Lymphoma, Large B-Cell, Diffuse 84Leukemia, Lymphocytic, Chronic, B-Cell 83

Interventions

olaparib 1lutetium Lu 177 dotatate 1fluorodopa F 18 1cabozantinib 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Carcinoid Tumor × 30 days × Clear all
NCT04086485 2026-05-22

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
56 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT05263050 2026-05-22

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Fox Chase Cancer Center

Phase 2 Recruiting
111 enrolled
EndocrineGenitourinaryNET

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT00646022 2026-05-12

Natural History of Familial Carcinoid Tumor

National Institutes of Health Clinical Center (CC)

Recruiting
1,600 enrolled
Endocrine

Carcinoid Tumor

NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT05064514 2026-05-08

TRICAR

Queen Mary University of London

Phase NA Active not recruiting
15 enrolled
Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡